GlaxoSmithKline [GLAXO] vs Senores [SENORES] Detailed Stock Comparison

GlaxoSmithKline

NSE

Senores

NSE

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: GlaxoSmithKline wins in 11 metrics, Senores wins in 7 metrics, with 0 ties. GlaxoSmithKline appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	GlaxoSmithKline	Senores	Better
P/E Ratio (TTM)	50.31	46.89	Senores
Price-to-Book Ratio	24.56	4.09	Senores
Debt-to-Equity Ratio	0.51	38.75	GlaxoSmithKline
PEG Ratio	48.86	0.34	Senores
EV/EBITDA	38.72	28.65	Senores
Profit Margin (TTM)	25.41%	14.82%	GlaxoSmithKline
Operating Margin (TTM)	29.27%	20.42%	GlaxoSmithKline
EBITDA Margin (TTM)	29.27%	20.42%	GlaxoSmithKline
Return on Equity	47.54%	7.21%	GlaxoSmithKline
Return on Assets (TTM)	22.58%	4.77%	GlaxoSmithKline
Free Cash Flow (TTM)	$12.65B	$-2.03B	GlaxoSmithKline
Dividend Yield	1.65%	N/A	N/A
1-Year Return	-6.38%	12.90%	Senores
Price-to-Sales Ratio (TTM)	12.81	6.94	Senores
Enterprise Value	$454.33B	$29.43B	GlaxoSmithKline
EV/Revenue Ratio	12.15	6.46	Senores
Gross Profit Margin (TTM)	64.27%	52.91%	GlaxoSmithKline
Revenue per Share (TTM)	$221	$116	GlaxoSmithKline
Earnings per Share (Diluted)	$56.23	$14.64	GlaxoSmithKline
Beta (Stock Volatility)	0.06	N/A	N/A

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

GlaxoSmithKline vs Senores Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
GlaxoSmithKline	-1.32%	-15.34%	-18.49%	-6.07%	21.26%	19.95%
Senores	-2.20%	-3.10%	16.33%	34.83%	13.40%	16.85%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
GlaxoSmithKline	-6.38%	85.69%	76.49%	-27.19%	36.57%	487.72%
Senores	12.90%	12.90%	12.90%	12.90%	12.90%	12.90%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

GlaxoSmithKline (GLAXO): View Full Stock Overview

Senores (SENORES): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: GlaxoSmithKline vs Senores

Metric	GLAXO	SENORES
Market Information
Market Cap i	₹479.22B	₹31.62B
Market Cap Category	Large cap	Small cap
10 Day Avg. Volume i	108,705	1,538,702
90 Day Avg. Volume i	102,776	720,296
Last Close	₹2,642.20	₹654.90
52 Week Range	₹1,921.00 - ₹3,515.70	₹435.25 - ₹719.00
% from 52W High	-24.85%	-8.92%
All-Time High	₹3,872.00 (Mar 28, 2016)	₹719.00 (Jul 30, 2025)
% from All-Time High	-31.76%	-8.92%
Growth Metrics
Quarterly Revenue Growth	-0.01%	0.72%
Quarterly Earnings Growth	0.12%	0.84%
Financial Health
Profit Margin (TTM) i	0.25%	0.15%
Operating Margin (TTM) i	0.29%	0.20%
Return on Equity (TTM) i	0.48%	0.07%
Debt to Equity (MRQ) i	0.51	38.75
Cash & Liquidity
Book Value per Share (MRQ)	₹115.19	₹168.00
Cash per Share (MRQ)	₹147.46	₹89.88
Operating Cash Flow (TTM) i	₹12.73B	₹-71,800,000
Levered Free Cash Flow (TTM) i	₹9.28B	₹585.60M
Dividends
Last 12-Month Dividend Yield i	1.65%	N/A
Last 12-Month Dividend i	₹54.00	N/A

Valuation & Enterprise Metrics Analysis: GlaxoSmithKline vs Senores

Metric	GLAXO	SENORES
Price Ratios
P/E Ratio (TTM) i	50.31	46.89
Forward P/E i	48.86	17.49
PEG Ratio i	48.86	0.34
Price to Sales (TTM) i	12.81	6.94
Price to Book (MRQ) i	24.56	4.09
Market Capitalization
Market Capitalization i	₹479.22B	₹31.62B
Enterprise Value i	₹454.33B	₹29.43B
Enterprise Value Metrics
Enterprise to Revenue i	12.15	6.46
Enterprise to EBITDA i	38.72	28.65
Risk & Other Metrics
Beta i	0.06	N/A
Book Value per Share (MRQ) i	₹115.19	₹168.00

Financial Statements Comparison: GlaxoSmithKline vs Senores

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	GLAXO	SENORES
Revenue/Sales i	₹8.05B	₹1.14B
Cost of Goods Sold i	₹2.88B	₹574.50M
Gross Profit i	₹5.17B	₹567.60M
Research & Development i	N/A	N/A
Operating Income (EBIT) i	₹2.36B	₹142.10M
EBITDA i	₹2.95B	₹312.10M
Pre-Tax Income i	₹2.79B	₹206.80M
Income Tax i	₹739.70M	₹27.10M
Net Income (Profit) i	₹2.05B	₹179.70M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	GLAXO	SENORES
Cash & Equivalents i	₹5.39B	₹1.05B
Total Current Assets i	₹34.10B	₹7.22B
Total Current Liabilities i	₹19.05B	₹2.41B
Long-Term Debt i	₹24.92M	₹1.71B
Total Shareholders Equity i	₹19.51B	₹8.12B
Retained Earnings i	₹10.59B	N/A
Property, Plant & Equipment i	₹2.70B	₹2.08B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	GLAXO	SENORES
Operating Cash Flow i	N/A	N/A
Capital Expenditures i	N/A	N/A
Free Cash Flow i	N/A	N/A
Debt Repayment i	N/A	N/A
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	GLAXO	SENORES
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Average Daily Volume (10 Day) i	108,705	1,538,702
Average Daily Volume (90 Day) i	102,776	720,296
Shares Outstanding i	169.41M	46.05M
Float Shares i	41.29M	18.03M
% Held by Insiders i	0.76%	0.56%
% Held by Institutions i	0.09%	0.06%

Dividend Analysis & Yield Comparison: GlaxoSmithKline vs Senores

Metric	GLAXO	SENORES
Last 12-Month Dividend i	₹54.00	N/A
Last 12-Month Dividend Yield i	1.65%	N/A
3-Year Avg Annual Dividend i	₹59.33	N/A
3-Year Avg Dividend Yield i	1.86%	N/A
3-Year Total Dividends i	₹178.00	N/A
Ex-Dividend Date	May 30, 2025	N/A

GlaxoSmithKline [GLAXO] vs Senores [SENORES] Detailed Stock Comparison